In Nigeria, Tuberculosis (TB) remains a significant health problem, with many people falling ill and dying.
Nigeria ranks 6th among the 30 countries with highest TB burden in the world and 1st in Africa. Nigeria comes third behind only India and China in terms of tuberculosis cases. Every year, around 245,000 Nigerians die from tuberculosis (TB) and about 590,000 new cases occur. TB accounts for more than 10% of all deaths in Nigeria.
The BCG Vaccine is the only available vaccine that is highly effective against tuberculosis. A safe and cost-effective vaccine that has been used for almost a century and has been credited with saving countless lives worldwide.
Patients who received the vaccine were much less likely to fall ill than those who did not. And a study conducted in Nigeria found that BCG vaccination reduced the risk of developing active TB by 64% among children under the age of 5.
Despite the success of the vaccine, Nigeria has faced challenges with its supply and distribution. The procurement and distribution of the BCG vaccine had issues, leading to stockouts in some areas, according to NPHCDA 2019 report. In 2020, BCG vaccination coverage was 68%, according to the World Health Organization (WHO).
Using this data, the government launched a massive vaccination campaign to prevent the spread of TB. They analysed the data to target the most vulnerable areas and raise awareness of the importance of vaccination. As a result, TB incidence dropped significantly, leading to a healthier and happier population.
However, the fight is not over, with recent research exploring the potential protective effects of the BCG vaccine against COVID-19. The push for improved data collection and analysis continues to improve health outcomes, requiring collaboration between policymakers, healthcare providers, community leaders, and advocates. By working together and addressing misconceptions, more people in Nigeria can be protected from TB using the BCG vaccine.
NSSF is taking steps and advocating for everyone to get immunized, especially infants and young children in areas where TB is common. This will reduce the risk of severe TB infections, particularly in children.
To keep up with our latest news, activities, and events, check out our insights page here.
Content created and supplied by: NSSF (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More